Experience with the COVID-19 AstraZeneca vaccination in people with multiple sclerosis.
- DOI
- 10.1016/j.msard.2021.103028
- Published
- 2021 Jul
- Container
- Multiple sclerosis and related disorders
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.msard.2021.103028,
title = {Experience with the COVID-19 AstraZeneca vaccination in people with multiple sclerosis.},
author = {Allen-Philbey K and Stennett A and Begum T and Johnson AC and Dobson R and Giovannoni G and Gnanapavan S and Marta M and Smets I and Turner BP and Baker D and Mathews J and Schmierer K},
year = {2021},
journal = {Multiple sclerosis and related disorders},
doi = {10.1016/j.msard.2021.103028},
url = {https://doi.org/10.1016/j.msard.2021.103028}
}RIS
TY - JOUR TI - Experience with the COVID-19 AstraZeneca vaccination in people with multiple sclerosis. AU - Allen-Philbey K AU - Stennett A AU - Begum T AU - Johnson AC AU - Dobson R AU - Giovannoni G AU - Gnanapavan S AU - Marta M AU - Smets I AU - Turner BP AU - Baker D AU - Mathews J AU - Schmierer K PY - 2021 JO - Multiple sclerosis and related disorders DO - 10.1016/j.msard.2021.103028 UR - https://doi.org/10.1016/j.msard.2021.103028 ER -
APA
K, A., A, S., T, B., AC, J., R, D., G, G., S, G., M, M., I, S., BP, T., D, B., J, M., & K, S. (2021). Experience with the COVID-19 AstraZeneca vaccination in people with multiple sclerosis.. Multiple sclerosis and related disorders. https://doi.org/10.1016/j.msard.2021.103028
Source records
- pubmed · retrieved 2026-09-27T10:29:07.864Z